EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through real-world experiences, the panel discusses how primary care…
PRESS RELEASE 3 December 2025 On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling…
The DECISION consortium has just published a fundamental study in the Journal of Hepatology on immune mechanisms predicting outcomes in patients with acutely decompensated cirrhosis (ADC). By analysing whole-blood RNA-sequencing (RNA-seq) data from over 1,200+ patients, researchers identified maladaptive emergency…
In recent years, the Journal of Hepatology has witnessed a marked increase in the number of Letters to the Editor submitted for consideration. While we continue to value thoughtful academic dialogue and constructive critique of published work, we have observed…
Amsterdam, May 2, 2024 – New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of Hepatology, published by Elsevier, details. "In clinical practice…
The Journal of Hepatology, EASL's flagships journal, has been in circulation since 1985. With an Impact Factor of 25.7 as of 2022, it stands as the foremost hepatology-exclusive journal. Journal of Hepatology is an innovative Journal publishing articles on global…
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people diagnosed with or dying from primary liver cancer…
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing the use of living donor liver transplantation (LDLT)…
EASL has launched several highly influential Clinical Practice Guidelines (CPGs). The objective of these CPGs is to provide simple, clear, and evidence-based guidelines that can be used for patient management and reimbursement policies all over Europe. EASL CPGs have become…
ClarivateTM Analytics released the 2022 update of its Journal Citation Reports©, including the much anticipated 2021 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2021 impact factor of 30.083, up from the 2020…